How PharmEasy’s ‘Ghatkopar Gujju Gang’ Pulled Off The Thyrocare Acquisition

How PharmEasy’s ‘Ghatkopar Gujju Gang’ Pulled Off The Thyrocare Acquisition

SUMMARY

As six-year-old tech unicorn PharmEasy acquires publicly-listed diagnostics chain Thyrocare, many believe it is a pivotal moment for startups in India

CEO Siddharth Shah says the strong bond between the five PharmEasy cofounders gives the company significant management bandwidth to create impact in every vertical

The cofounder added that PharmEasy’s vision is being a single platform for medical and health information, consultation, diagnostics, medicines and medical products

In the world of startups, some success stories are scripted because of the singular vision and focus of a solo entrepreneur, while others are about accommodating several leaders or cofounders on an equal footing. The latter is more often than not fraught with peril, with many a great-idea-turned-startup becoming untenable because of a clash or disagreement between cofounders.

That is something of an alien feeling for Siddharth Shah, the cofounder and CEO of healthtech unicorn PharmEasy, who refers to himself and fellow cofounders — Dharmil Sheth, Dhaval Shah, Harsh Parekh, Hardik Dedhia — as the Ghatkopar Gujju Gang.

modal lock
You're In Private Mode!

want to read the full story?

Login or create a free account to continue reading in private mode.